Intercept Pharmaceuticals

+$0.32 (+2.09%) As of 5:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ICPT and other ETFs, options, and stocks.

About ICPT

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases.

CEO
Jerome B. Durso
Employees
437
Headquarters
Morristown, New Jersey
Founded
2002

ICPT Key Statistics

Market cap
463.82M
Price-Earnings ratio
—
Dividend yield
—
Average volume
579.46K
High today
$15.83
Low today
$13.33
Open price
$13.35
Volume
2.01M
52 Week high
$20.50
52 Week low
$10.81

ICPT News

MarketWatch5h

Intercept Reports More Positive Phase 3 Data From NASH Study >ICPT - MarketWatch

By Colin Kellaher Intercept Pharmaceuticals Inc. on Thursday reported positive topline results from an interim analysis of its pivotal Phase 3 study of its pro

ICPT Earnings

-$1.58
-$1.05
-$0.53
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure